BRIEF-Oxigene receives fast track status from U.S. FDA for CA4P
March 30, 2016 at 08:48 AM EDT
* Oxigene receives fast track designation from U.S. FDA for CA4P Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)